Task: Answer the multiple choice question.
Question: Which compound exhibits a -22.751% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a O=C(NC(=S)N1CCCC1)c1ccccc1F
b O=C(Cn1nc(Cl)nc1Cl)c1ccc([N+](=O)[O-])cc1
c CCN(CC(=O)NCc1ccc(F)cc1)CC(=O)Nc1ccc(S(=O)(=O)N2CCCC2)cc1
d Cc1cc(C)c[n+](-c2[nH]c(=O)sc2/C=N/N=C(\N)[S-])c1
e Cc1nc2ncnn2c(C)c1CCC(=O)N1CCCCC1
Answer: c. CCN(CC(=O)NCc1ccc(F)cc1)CC(=O)Nc1ccc(S(=O)(=O)N2CCCC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(CC(=O)NCc1ccc(F)cc1)CC(=O)Nc1ccc(S(=O)(=O)N2CCCC2)cc1
CCN(CC(=O)NCc1ccc(F)cc1)CC(=O)Nc1ccc(S(=O)(=O)N2CCCC2)cc1
2-[ethyl-[2-oxo-2-(4-pyrrolidin-1-ylsulfonylanilino)ethyl]amino]-N-[(4-fluorophenyl)methyl]acetamide